v3.26.1
Consolidated Statements of Stockholders’ Deficit - USD ($)
Previously Reported
Shares pending issuance Amounts
Previously Reported
Common stock
Previously Reported
Additional paid-in capital
Previously Reported
Accumulated deficit
Previously Reported
Accumulated other comprehensive income/(loss)
Previously Reported
Retroactive application of First Reverse Stock Split
Shares pending issuance Amounts
 [1]
Retroactive application of First Reverse Stock Split
Common stock
 [1]
Retroactive application of First Reverse Stock Split
Additional paid-in capital
 [1]
Retroactive application of First Reverse Stock Split
Accumulated deficit
 [1]
Retroactive application of First Reverse Stock Split
Accumulated other comprehensive income/(loss)
 [1]
Retroactive application of First Reverse Stock Split
 [1]
Retroactive application of Second Reverse Stock Split
Shares pending issuance Amounts
 [1]
Retroactive application of Second Reverse Stock Split
Common stock
 [1]
Retroactive application of Second Reverse Stock Split
Additional paid-in capital
 [1]
Retroactive application of Second Reverse Stock Split
Accumulated deficit
 [1]
Retroactive application of Second Reverse Stock Split
Accumulated other comprehensive income/(loss)
 [1]
Retroactive application of Second Reverse Stock Split
 [1]
Shares pending issuance Amounts
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income/(loss)
Total
Balance at Mar. 31, 2024 $ 6,319 $ 272,057,003 $ (307,551,502) $ 1,795,992 $ (33,692,188) $ (6,256) $ 6,256 $ (60) $ 60 $ 3 $ 272,063,319 $ (307,551,502) $ 1,795,992 $ (33,692,188)
Balance (in Shares) at Mar. 31, 2024   63,185,881           (62,553,508)           (600,213)           32,160        
Stock based compensation                                       52,461 52,461
Issue of common stock against Atalaya note                                       $ 1 2,324,695 2,324,696
Issue of common stock against Atalaya note (in Shares)                                       6,257        
Issue of common stock warrants along with redeemable promissory notes                                       2,047,925 2,047,925
Issue of common stock warrants to placement agents against Redeemable Promissory Note                                       418,157 418,157
Issuance of common stock upon conversion of unsecured promissory note to related party                                       2,027,840 2,027,840
Issuance of common stock upon conversion of unsecured promissory note to related party (in Shares)                                       338        
Issue of common stock upon exercise of warrants along with redeemable promissory notes                                       $ 5 (5)
Issue of common stock upon exercise of warrants along with redeemable promissory notes (in Shares)                                       46,527        
Issue of common stock and warrants on fund raise [2]                                     $ 25 2,568,530 2,568,555
Issue of common stock and warrants on fund raise (in Shares) [2]                                       250,429        
Issue of common stock and warrants on settlement [2]                                     $ 52 16,158,761 16,158,813
Issue of common stock and warrants on settlement (in Shares) [2]                                       523,317        
Issue of common stock warrants to placement agents                                       48,405 48,405
Issuance costs towards common stock and warrants                                       (616,440) (616,440)
Issue of common stock upon exercise of warrants [2]                                     $ 152 232,909 233,061
Issue of common stock upon exercise of warrants (in Shares) [2]                                       1,521,097        
Reclassification of debt to equity                                       8,366,650 8,366,650
Reverse stock split rounding adjustment                                       $ 8 (8)
Reverse stock split rounding adjustment (in Shares)                                       82,293        
Gain on employee benefit, (net of taxes amounts to $NIL)                                       (64,287) (64,287)
Net loss                                       (25,622,303) (25,622,303)
Foreign currency translation adjustment, (net of taxes amounts to $NIL)                                       399,817 399,817
Balance at Mar. 31, 2025                                     $ 246 305,693,199 (333,173,805) 2,131,522 (25,348,838)
Balance (in Shares) at Mar. 31, 2025                                       2,462,418        
Stock based compensation [2]                                     142,500 883,968 1,026,468
Stock based compensation (in Shares) [2]                                              
Transfer of vested RSU to shares pending issuance                                     24,038 (24,038)
Translation adjustment on derecognition of subsidiary                                       (1,293,717) (1,293,717)
Shares cancelled [3]                                       $ 0 0
Shares cancelled (in Shares) [3]                                       (1,384)        
Issue of common stock                                     $ 634 [4] (596) [4] [4] [4] 38 [4]
Issue of common stock (in Shares) [4]                                       6,340,619        
Issue of prefunded warrants in exchange of common stock                                     $ (240) [4] 240 [4] [4] [4] [4]
Issue of prefunded warrants in exchange of common stock (in Shares) [4]                                       (2,400,310)        
Issue of prefunded warrants [4]                                     2,931,457 2,931,457
Issue of common stock warrants                                       939 939
Warrants pending issuance in lieu of placement agent fees                                       14,139 14,139
Gain on employee benefit, (net of taxes amounts to $NIL)                                       (46,218) (46,218)
Net loss                                       (14,621,113) (14,621,113)
Shares issued under employee stock plans [2]                                     $ 103 427,397 427,500
Shares issued under employee stock plans (in Shares) [2]                                       1,032,648        
Foreign currency translation adjustment, (net of taxes amounts to $NIL)                                       1,605,278 1,605,278
Balance at Mar. 31, 2026                                     $ 166,538 $ 743 $ 309,926,705 $ (347,794,918) $ 2,396,865 $ (35,304,067)
Balance (in Shares) at Mar. 31, 2026                                       7,433,991        
[1] Prior period numbers have been adjusted to reflect the First Reverse Stock Split and the Second Reverse Stock Split of the Common Stock at a ratio of 1-for-100 and 1-for-20 respectively. (Refer Note 3A)
[2] Includes cost recorded towards restricted shares granted to CEO and RSU granted to directors/employees of the Company
[3] The amount of Common stock presented as zero represents decimal value less than $1.
[4] Refer Note 19 for the details of the common stock and warrants issued and exercised during the year.